Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Global Autoimmune Disease Therapeutics Market: Impact Analysis of COVID-19 (2021-2025)The key players of the autoimmune disease therapeutics market are Roche Holding AG, Pfizer Inc., Johnson & Johnson, and Abbott Laboratories are also profiled with their financial information and respective business strategies.
By: Daedal Research The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global autoimmune disease therapeutics market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Country Coverage North America Europe Asia Pacific Middle East & Africa Latin America Company Coverage Roche Holding AG Pfizer Inc. Johnson & Johnson Abbott Laboratories Executive Summary An autoimmune disease is a condition in which the body's immune system attacks and destroys healthy cells and tissues in the body by mistake. In other words, autoimmune disease arises when the immune system fails to distinguish between the body's own cells and foreign cells. These diseases can affect any part of the body. Autoimmune disease therapeutics is a form of treatment to calm the overactive immune response, to limit tissue damage, and to reduce pain and inflammation. Treatment can also help in relieving symptoms like pain, swelling, and skin rashes. There are a lot of therapeutic alternatives available, but no option has a perfect safety profile. Infact, while some treatments have been effective in treating certain autoimmune disorders, no treatment is effective for all autoimmune diseases. The autoimmune disease therapeutics market can be segmented on the basis of drug class (Immunosuppressant's, Anti-inflammatory Drug, Interferons, NSAIDs, Antihyperglycemics, and Others); indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes, Psoriasis, and Others); and distribution channel (Hospital & Clinics, Pharmacies, Drug Stores, Online Stores, and Others). For further details, kindly visit : https://www.daedal- Rajeev Kumar (Business Development Manager) Address: 36 SFS Flats Paschim Vihar New Delhi-110063 Mobile: +91-9811715635 Tel: +91-120-4553017 Mail ID - info@daedal- End
Account Email Address Account Phone Number Disclaimer Report Abuse Page Updated Last on: Feb 22, 2021
|
|